Feb. 16, 2024, 12:18 p.m. |

Bloomberg Technology bloomberg.com

Novartis CEO Vas Narasimhan talks about acquisitions, AI and the future of weight-loss drugs. He speaks on "The David Rubenstein Show: Peer-to-Peer Conversations." This interview was recorded Feb. 15 in New York. (Source: Bloomberg)

acquisitions bloomberg ceo conversations david drugs future interview loss novartis peer peer-to-peer show talks weight-loss

Data Architect

@ University of Texas at Austin | Austin, TX

Data ETL Engineer

@ University of Texas at Austin | Austin, TX

Lead GNSS Data Scientist

@ Lurra Systems | Melbourne

Senior Machine Learning Engineer (MLOps)

@ Promaton | Remote, Europe

Field Sample Specialist (Air Sampling) - Eurofins Environment Testing – Pueblo, CO

@ Eurofins | Pueblo, CO, United States

Camera Perception Engineer

@ Meta | Sunnyvale, CA